-
101
-
102
Biochemical mechanisms and molecular interactions of vitamins in cancer therapy
Published 2025-01-01Get full text
Article -
103
Clinical analysis and risk factors associated with poor prognosis in nontuberculous mycobacterial infection
Published 2025-12-01Get full text
Article -
104
Enhancing environmental decontamination and sustainable production through synergistic and complementary interactions of actinobacteria and fungi
Published 2025-02-01“…Co-cultures of actinobacteria and fungi harness a broader range of genes and metabolic capabilities through their distinctive interactions, opening new avenues for developing novel products and/or technologies. This review provides a critical analysis of the present status of knowledge regarding the potential of actinobacteria-fungi co-cultures with a particular focus on novel functionalities and heightened production efficiency. …”
Get full text
Article -
105
Etiology of Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) in Tertiary-Care Hospitals in Thailand: A Multicenter, Retrospective Cohort Study
Published 2025-01-01“…Medical records of patients with a documented diagnosis of nosocomial pneumonia (NP) were systematically reviewed to collect data on demographic, clinical, microbiological, and 30-day readmission due to NP.Results: A total of 240 patients were included in the study, comprises patients with VAP (62.9%), HAP (36.7%), and ventilated HAP (vHAP) (0.4%). …”
Get full text
Article -
106
Clinical Characteristics and Optimization of Empirical Antimicrobial Therapy for Febrile Neutropenia in Patients With Hematologic Malignancies
Published 2025-02-01“…The study aims to update and optimize empirical treatment strategies for hematological malignancy (HM) patients, a population particularly vulnerable to these evolving threats.Methods: A literature review was conducted on studies published between January 2010 and December 2023 regarding empirical treatment of FN in HM patients, focusing on pathogen characteristics, treatment regimens, and duration of therapy.Results: Approximately one-third of HM patients with FN experience fever of unknown origin (FUO), while 40– 50% have clinically documented infections (CDI), and 10– 30% present with microbiologically documented infections (MDI), with a predominance of Gram-negative bacteria (GNB). …”
Get full text
Article -
107
Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventiona...
Published 2022-07-01“…Better diagnostics, together with tools to predict disease progression, are critical for achieving WHO End-TB targets. The Early Risk Assessment in TB Contacts by new diagnoStic tEsts (ERASE-TB) study aims to evaluate novel diagnostics and testing algorithms for early TB diagnosis and accurate prediction of disease progression among household contacts (HHCs) exposed to confirmed index cases in Mozambique, Tanzania and Zimbabwe.Methods and analysis A total of 2100 HHCs (aged ≥10 years) of adults with microbiologically-confirmed pulmonary TB will be recruited and followed up at 6-month intervals for 18–24 months. …”
Get full text
Article